Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825373 | Clinical Therapeutics | 2014 | 12 Pages |
Abstract
To our knowledge, this is the first study to quantify and aggregate the continuous relationship between the risk of GI or CV events and the dosage of an NSAID. With the recent availability of new low doses of diclofenac, the models may be used to estimate the potential reduction in risk of adverse events at these doses.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Dawn M. MS, Deirdre M. BA, Kenneth G. MD, MSc, Bintu N. MS, LaStella MS, Naoko PhD, Jianmin PhD,